<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.38911.010</object-id><label>Table 1.</label><caption><title>Empirical results for the effect of <italic>irx3b</italic> morpholino on <italic>cdh17</italic>, <italic>stc1</italic> and <italic>slc12a1</italic> expression at 24 hpf, 36 hpf and 50 hpf Un-injected wild-type embryos showed no phenotypes in the pronephros.</title><p>The phenotypes for <italic>irx3b</italic> morphants are: <italic>slc12a1</italic>, reduction in staining; <italic>stc1</italic>, increased/ectopic staining; <italic>cdh17</italic>, expanded DL domain, reduced DE staining and reduced/stretched PST segment. Experiments were repeated multiple times (at least three times) and the results showed are from one representative experiment.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top"><bold><italic>slc12a1</italic>/<italic>stc1</italic></bold></th><th valign="top"><bold>24 hpf</bold></th><th valign="top"><bold>36 hpf</bold></th><th valign="top"><bold>50 hpf</bold></th></tr></thead><tbody><tr><td valign="top">&#8195;Un-injected</td><td valign="top">33</td><td valign="top">34</td><td valign="top">33</td></tr><tr><td valign="top">&#8195;<italic>irx3b<sup>mo</sup> slc12a1</italic> phenotype</td><td valign="top">17/23</td><td valign="top">27/32</td><td valign="top">30/39</td></tr><tr><td valign="top">&#8195;<italic>irx3b<sup>mo</sup> stc1</italic> phenotype</td><td valign="top">18/23</td><td valign="top">27/32</td><td valign="top">33/39</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th valign="top"><bold><italic>cdh17</italic>/<italic>stc1</italic></bold></th><th valign="top"><bold>24 hpf</bold></th><th valign="top"><bold>36 hpf</bold></th><th valign="top"><bold>50 hpf</bold></th></tr></thead><tbody><tr><td valign="top">&#8195;Un-injected</td><td valign="top">27</td><td valign="top">30</td><td valign="top">31</td></tr><tr><td valign="top">&#8195;<italic>irx3b<sup>mo</sup> cdh17</italic> phenotype</td><td valign="top">25/27</td><td valign="top">29/31</td><td valign="top">30/38</td></tr><tr><td valign="top">&#8195;<italic>irx3b<sup>mo</sup> stc1</italic> phenotype</td><td valign="top">22/27</td><td valign="top">26/31</td><td valign="top">31/38</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th valign="top"><bold><italic>cdh17</italic>/<italic>slc12a1</italic></bold></th><th valign="top"><bold>24 hpf</bold></th><th valign="top"><bold>36 hpf</bold></th><th valign="top"><bold>50 hpf</bold></th></tr></thead><tbody><tr><td valign="top">&#8195;Un-injected</td><td valign="top">23</td><td valign="top">23</td><td valign="top">27</td></tr><tr><td valign="top">&#8195;<italic>irx3b<sup>mo</sup> cdh17</italic> phenotype</td><td valign="top">24/27</td><td valign="top">29/30</td><td valign="top">32/35</td></tr><tr><td valign="top">&#8195;<italic>irx3b<sup>mo</sup> slc12a1</italic> phenotype</td><td valign="top">26/27</td><td valign="top">27/30</td><td valign="top">34/35</td></tr></tbody></table></table-wrap>